NCT04921176View on ClinicalTrials.gov

Evaluating Quality of Life of AF Patients Following a Bleed

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

December 22, 2020

Primary Completion Date

March 9, 2022

Study Completion Date

March 9, 2022

Conditions
Atrial Fibrillation
Trial Locations (3)

OX7 5SR

Arrhythmia Alliance, Oxford

SA6 6NL

Morriston Hospital, Swansea

Unknown

Swansea City GP Cluster, Swansea

Sponsors
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Pfizer

INDUSTRY

lead

Swansea University

OTHER

NCT04921176 - Evaluating Quality of Life of AF Patients Following a Bleed | Biotech Hunter | Biotech Hunter